Type II kinase inhibitors that target Parkinson’s disease–associated LRRK2

Journal:

Science Advances

Published:

2025-06-06

DOI:

10.1126/sciadv.adt2050

Affiliations:

7

Authors:

14

Go to article

Institutions	Authors	Share
Goethe University Frankfurt (GU), Germany	3.666667	0.26
Structural Genomics Consortium (SGC Frankfurt), Germany	3.666667	0.26
Aligning Science Across Parkinson's (ASAP), United States of America (USA)	3.333333	0.24
University of California, San Diego (UC San Diego), United States of America (USA)	3.333333	0.24

Interested in Neurosciences?